Puerarin alleviates diabetic nephropathy by inhibiting Caspase-1-mediated pyroptosis
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgad113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von QiuYan Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical College, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, Guangxi 530021, PR China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus, Isoflavones. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Joint Project on Regional High-Incidence Diseases Research of Guangxi.
Abstract (Originalsprache)
Background and purpose Diabetic nephropathy (DN) is an important cause of end-stage renal disease, with podocyte injury as the main feature. Pyroptosis plays a non-negligible role in the process of diabetic nephropathy. Puerarin (PR) treatment of diabetic nephropathy has great potential, but the mechanism is not very clear. This article aims to study the protective effect and mechanism of puerarin on DN.
Methods
Streptozotocin (STZ)-induced C57 BL/6J mouse model of DN was given PR, Necrosulfomide (NSA), Nigericin for 12 weeks; A 60 mM high glucose(HG) induced MPC5 cell injury model was administered to PR, NSA, and Nigericin interventions for 24 h.
Results
After 12 weeks of administration, PR reduced fasting blood glucose levels in DN mice, alleviated glomerular lesions, reduced podocyte damage, and protected renal function. Meanwhile, PR also inhibits the expression of pyroptosis-related proteins. In addition, PR alleviated the release of Interleukin 18 (IL-18), Interleukin 1beta (IL-1β), and lactate dehydrogenase (LDH) in MPC5 cells under HG conditions, downregulated the expression of pyrozozois-related proteins, and improved Caspase-1-mediated pyroptosis in MPC5 cells.
Conclusion
Our study suggests that the beneficial effects of PR in diabetic nephropathy may be associated with inhibition of Caspase-1-mediated pyroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical College, Guangxi Medical University, No. 22, Shuangyong Road, Nanning, Guangxi 530021, PR China.
- Department of Pharmacy, Guangxi Medical University Cancer Hospital, No. 71, Hedi Road, Nanning, Guangxi 530021, PR China.
- College of Basic Medicine, Guangxi University of Chinese Medicine, No. 13, Wuhe Road, Nanning, Guangxi 530200, PR China.
- College & Hospital of Stomatology, Guangxi Medical University, No. 10, Shuangyong Road, Nanning, Guangxi 530021, PR China.
- Key Laboratory of Research and Application of Stomatological Equipment (College of Stomatology, Hospital of Stomatology, Guangxi Medical University), Education Department of Guangxi Zhuang Autonomous Region, No. 10, Shu…
Förderung
- National Natural Science Foundation of China
- Joint Project on Regional High-Incidence Diseases Research of Guangxi
Zitieren
APA
Chen, Q., Wang, L., Wei, X., Chen, M., Zhang, X., Mo, R., Huang, R., Liang, T., & Xu, X. (2024). Puerarin alleviates diabetic nephropathy by inhibiting Caspase-1-mediated pyroptosis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad113
Vancouver
Chen Q, Wang L, Wei X, Chen M, Zhang X, Mo R, et al. Puerarin alleviates diabetic nephropathy by inhibiting Caspase-1-mediated pyroptosis. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgad113
BibTeX
@article{Chen2024,
author = {Chen, QiuYan and Wang, Lu and Wei, Xiaojie and Chen, Ming and Zhang, Xiaoping and Mo, Rou and Huang, Renbin and Liang, Tao and Xu, Xiaohui},
title = {Puerarin alleviates diabetic nephropathy by inhibiting Caspase-1-mediated pyroptosis},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgad113}
}
EUVIMED